4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000842023-14-000014
Senior VP - Biotech sold 3,591 shares at an average $89.35 ($320,844)
- Senior VP - Biotech acquired 3,591 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
REAGAN KEVIN J · Senior VP - Biotech
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-12-05 | Exercise or conversion : show line 1 in the form | +1,000 | $70.96 | $70,960 | 1,000 | D |
| 2014-12-05 | Sale : show line 2 in the form | −1,000 | $89.41 | $89,412 | 0 | D |
| 2014-12-09 | Exercise or conversion : show line 3 in the form | +2,591 | $70.96 | $183,857 | 2,591 | D |
| 2014-12-09 | Sale : show line 4 in the form | −2,591 | $89.32 | $231,432 | 0 | D |
| Open-market sales · 3,591 sh · avg $89.35 · $320,844 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-12-05 | Exercise or conversion : show line 5 in the form Stock Option | −1,000 | $70.96 | 2019-01-23 | 1,000 | 9,773 | D |
| 2014-12-09 | Exercise or conversion : show line 6 in the form Stock Option | −2,591 | $70.96 | 2019-01-23 | 2,591 | 7,182 | D |
Loading xslF345X03/primary_doc.xml…